Taxotere Lawsuit Seek Class-Action Status Alleging Permanent Hair Loss After Receiving Chemotherapy Drug

   

Taxotere Lawsuit Filings Allege Women Experience Permanent Hair Loss or Alopecia After Receiving The Chemotherapy Drug

taxotere lawsuit taxotere hair-loss-lawsuit side effects hair lossThree Louisiana women have asked a federal court judge to certify their Taxotere lawsuit as a class action on behalf of all the women in Louisiana affected by the chemotherapy drug. The women’s lawsuit joined hundreds of Taxotere hair loss lawsuits pending in a multidistrict litigation (MDL) in the U.S. District Court, Eastern District of Louisiana. The lawsuits are filed on behalf of breast cancer survivors who have suffered permanent hair loss, also known as alopecia, economic damages, physical and mental pain and suffering, and other injuries allegedly due to Taxotere. (In Re: Taxotere (Docetaxel) Products Liability Litigation – Taxotere Lawsuit – MDL 2740)

Southern Med Law’s Taxotere attorneys are evaluating potential hair loss lawsuits from women who have suffered alopecia side-effects allegedly from the chemotherapy drug.

“Our attorneys have been answering questions from women who have been prescribed Taxotere and want to know the legal options available to them,” says Dr. François Blaudeau, founder of Southern Med Law.

If you have suffered from alopecia and other side effects after being prescribed the Taxotere chemotherapy drug to treat breast cancer, you can arrange for a free, no-obligation legal evaluation by calling Southern Med Law today at 205-547-5525 or visit www.southernmedlaw.com for more information and news on upcoming meetings and filings.

The three women filed their Taxotere lawsuit in December and allege they suffered permanent hair loss after taking the chemotherapy drug. On April 25, the women filed a motion that asked Judge Kurt D. Engelhardt, who is managing the Taxotere MDL, to certify their putative class-action complaint. The motion stated that women in Louisiana believed to be in the class “are so numerous as to make mass joinder an ineffective tool.” Therefore, certification is the “superior procedural device to handle these cases.” While a multidistrict litigation
manages individual cases in a coordinated manner prior to having separate trials for the cases, a class-action lawsuit, involves one lawsuit with multiple plaintiffs and one trial. According to the motion, a “class-action would result in definable class boundaries and in a single trial on the predominant issues.” (Taxotere Hair Loss Lawsuit Case No., 2:16-cv-17731; In Re: Taxotere (Docetaxel) Products Liability Litigation – Taxotere Lawsuit – MDL 2740)

Taxotere (docetaxel) was approved in 1996 by the U.S. Food and Drug Administration to treat various forms of cancer including locally advanced or metastatic breast cancer in women whose previous chemotherapy treatments failed. Taxotere is part of a family of drugs known as Taxanes which are widely used as chemotherapy agents. Taxanes block cell growth by interfering with cell division. In addition to hair loss, patients taking Taxotere reported side effects such as anemia, gastrointestinal bleeding, infections, nausea and vomiting, and skin reactions.
[accessdata.fda.gov/drugsatfda_docs/label/2010/020449s059lbl.pdf]

The Taxotere MDL was established in October 2016 for all federally filed Taxotere lawsuits. According to the Taxotere Hair Loss complaints, Taxotere has been scientifically linked to causing permanent hair loss and other side-effects. The complaints accuse Sanofi-Aventis and its subsidiaries which manufacture, market and distribute Taxotere, of misleading women to believe that Taxotere was safe, and failed to adequately warn about alopecia. The Taxotere lawsuits further assert that Sanonfi-Aventis marketed Taxotere as more effective than other chemotherapy drugs when other drugs were equally effective without the associated permanent hair loss. (In Re: Taxotere (Docetaxel) Products Liability Litigation – MDL 2740)

About Southern Med Law And Filing A Taxotere Hair Loss Lawsuit

Led by Dr. François Blaudeau, an attorney and a practicing obstetrician/ gynecologist, the legal staff at Southern Med Law possesses a deep understanding of the complex medical and legal questions at issue in Taxotere Hair Loss Lawsuits. They are not afraid to take on the nation’s largest corporations in their pursuit of justice, and are committed to ensuring that all victims have access to the type of aggressive legal advocacy that assures success. To speak to one of the firm’s Taxotere Hair Loss lawsuit attorneys for a FREE Taxotere Hair Loss Lawsuit consultation please call 205-547-5525 or fill out the online form.

Southern Med Law
François M. Blaudeau, MD JD FACHE FCLM Esquire
2224 1st Avenue North
Birmingham, Alabama 35203
Phone: (205) 547-5525
Fax: (205) 547-5526
francois@southernmedlaw.com
www.southernmedlaw.com
Medical Negligence/MedicalDevice/Pharma/Qui Tam

This entry was posted in Southern Med Law | Article. Bookmark the permalink.